Aktuellt
SENASTE
Redeye leaves a comment on InDex Pharmaceuticals following the announcement of its Q3 report. FPI in CONCLUDE is expected to be communicated anytime soon, and there is still a large gap to our fair value of InDex shares.
LÄS MER
